FDA Inspection 659514 — Compass Pharma Services, LLC

Compass Pharma Services, LLC — FEI 2211669

The FDA completed an inspection of Compass Pharma Services, LLC on May 4, 2010 in Clifton, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
May 4, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Clifton, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.